Enigma Prevents Cbl-c-Mediated Ubiquitination and Degradation of RETMEN2A

Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers

(2012) Libero Santarpia et al.   CURRENT PHARMACEUTICAL DESIGN

Alternative splicing results in RET isoforms with distinct trafficking properties

(2012) Douglas S. Richardson et al.   MOLECULAR BIOLOGY OF THE CELL

Cbl-c Ubiquitin Ligase Activity Is Increased via the Interaction of Its RING Finger Domain with a LIM Domain of the Paxillin Homolog, Hic 5

(2012) Philip E. Ryan et al.   PLoS One

Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization

(2011) Kuo-Jang Kao et al.   BMC CANCER

The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells

(2011) Chunyu Wang et al.   BREAST CANCER RESEARCH AND TREATMENT

A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer

(2011) Christos Hatzis   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice

(2010) Cho-Rok Jung et al.   JOURNAL OF CLINICAL INVESTIGATION

The Ret Receptor Tyrosine Kinase Pathway Functionally Interacts with the ER  Pathway in Breast Cancer

(2008) A. Boulay et al.   CANCER RESEARCH

CD2AP and Cbl-3/Cbl-c Constitute a Critical Checkpoint in the Regulation of Ret Signal Transduction

(2008) C. C. Tsui et al.   JOURNAL OF NEUROSCIENCE